NCT04482179View on ClinicalTrials.gov

Transcranial Magnetic Stimulation and Constraint Induced Language Therapy for Alzheimer Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

February 19, 2020

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
Alzheimer Disease
Interventions
DEVICE

Active TMS

Active TMS will be delivered at 100% motor threshold

BEHAVIORAL

CILT

60-90 minutes of CILT will be administered during each treatment session

DEVICE

Sham TMS

Sham TMS will be administered

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

lead

University of Pennsylvania

OTHER

NCT04482179 - Transcranial Magnetic Stimulation and Constraint Induced Language Therapy for Alzheimer Disease | Biotech Hunter | Biotech Hunter